학술논문

Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention Trial.
Document Type
article
Source
Subject
Epidemiology
Biomedical and Clinical Sciences
Clinical Sciences
Health Sciences
Prevention
Kidney Disease
Cardiovascular
Heart Disease
Clinical Research
Hypertension
Aging
Renal and urogenital
Good Health and Well Being
Clinical sciences
Language
Abstract
BackgroundUrinary Dickkopf-3 (uDKK3) is a tubular epithelial-derived profibrotic protein secreted into the urine under tubular stress. It is associated with kidney disease progression in persons with chronic kidney disease (CKD) and diabetes, and post-operative and contrast-associated acute kidney injury (AKI). We explored associations of uDKK3 with cardiovascular disease (CVD), kidney and mortality outcomes within the subset of Systolic Blood Pressure Intervention Trial (SPRINT) participants with non-diabetic CKD.MethodsWe included 2,344 participants with estimated glomerular filtration rate (eGFR) 30% (0.88; 0.79-0.99) or mortality (1.02; 0.87-1.20). For the linear eGFR change outcome, higher uDKK3 also had no association in the fully adjusted model (-0.03; -0.41-0.36).ConclusionsAmong individuals with hypertension and non-diabetic CKD, higher uDKK3 appeared to have associations with a greater risk of CVD events, incident ESKD, incident AKI, eGFR decline ≥30%, and mortality, but was not independent of eGFR and albuminuria.